Login
Home
Charts
Search
Watchlist
Products

Fischer Medical Ventures Ltd

FISCHER·BSE
₹35.03+6.09%Wed, 23 Sept '26
Industry:Chemicals - Inorganic
Indices:

Fischer Medical Ventures Ltd

FISCHER
BSE
₹35.03
+6.09%
|Wed, 23 Sept '26
SOICxStockScans Reports
Industry
Chemicals - Inorganic
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹2,448Cr
Close
Close Price
₹35.03
Industry
Industry
Chemicals - Inorganic
PE
Price To Earnings
89.82
PS
Price To Sales
6.67
Revenue
Revenue
₹367Cr
Rev Gr TTM
Revenue Growth TTM
195.82%
PAT Gr TTM
PAT Growth TTM
290.76%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
0211040124923861019882
Growth YoY
Revenue Growth YoY%
136.5131.6117.6760.498.4249.5
Expenses
ExpensesCr
0181039114719708010171
Operating Profit
Operating ProfitCr
03011341622-411
OPM
OPM%
12.1-1.71.34.35.117.518.821.3-3.813.7
Other Income
Other IncomeCr
00100072111
Interest Expense
Interest ExpenseCr
00000011144
Depreciation
DepreciationCr
00001111111
PBT
PBTCr
030002101721-88
Tax
TaxCr
00000153254
PAT
PATCr
03000151419-124
Growth YoY
PAT Growth YoY%
-45.24,150.04,693.16,751.7-976.1-22.0
NPM
NPM%
12.5-1.20.7-2.52.920.716.119.1-12.84.6
EPS
EPS₹
0.00.10.10.00.00.00.00.20.3-0.20.1
QuarterSep 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
0211040124923861019882
Growth YoY
Revenue Growth YoY%
136.5131.6117.6760.498.4249.5
Expenses
ExpensesCr
0181039114719708010171
Operating Profit
Operating ProfitCr
03011341622-411
OPM
OPM%
12.1-1.71.34.35.117.518.821.3-3.813.7
Other Income
Other IncomeCr
00100072111
Interest Expense
Interest ExpenseCr
00000011144
Depreciation
DepreciationCr
00001111111
PBT
PBTCr
030002101721-88
Tax
TaxCr
00000153254
PAT
PATCr
03000151419-124
Growth YoY
PAT Growth YoY%
-45.24,150.04,693.16,751.7-976.1-22.0
NPM
NPM%
12.5-1.20.7-2.52.920.716.119.1-12.84.6
EPS
EPS₹
0.00.10.10.00.00.00.00.20.3-0.20.1

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
021111309367
Growth
Revenue Growth%
11,588.8427.6178.8195.8
Expenses
ExpensesCr
019107265322
Operating Profit
Operating ProfitCr
0234345
OPM
OPM%
8.58.93.014.012.4
Other Income
Other IncomeCr
011126
Interest Expense
Interest ExpenseCr
00069
Depreciation
DepreciationCr
00234
PBT
PBTCr
0224639
Tax
TaxCr
0011514
PAT
PATCr
0213125
Growth
PAT Growth%
5,135.3-34.32,468.1290.8
NPM
NPM%
-20.38.81.110.16.7
EPS
EPS₹
-2.10.20.00.50.4
Financial YearMar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
021111309367
Growth
Revenue Growth%
11,588.8427.6178.8195.8
Expenses
ExpensesCr
019107265322
Operating Profit
Operating ProfitCr
0234345
OPM
OPM%
8.58.93.014.012.4
Other Income
Other IncomeCr
011126
Interest Expense
Interest ExpenseCr
00069
Depreciation
DepreciationCr
00234
PBT
PBTCr
0224639
Tax
TaxCr
0011514
PAT
PATCr
0213125
Growth
PAT Growth%
5,135.3-34.32,468.1290.8
NPM
NPM%
-20.38.81.110.16.7
EPS
EPS₹
-2.10.20.00.50.4

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
0546465
Reserves
ReservesCr
027244319
Current Liabilities
Current LiabilitiesCr
04102258
Non Current Liabilities
Non Current LiabilitiesCr
111827
Total Liabilities
Total LiabilitiesCr
086457672
Current Assets
Current AssetsCr
070365414
Non Current Assets
Non Current AssetsCr
01692258
Total Assets
Total AssetsCr
086457672
Financial YearMar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
0546465
Reserves
ReservesCr
027244319
Current Liabilities
Current LiabilitiesCr
04102258
Non Current Liabilities
Non Current LiabilitiesCr
111827
Total Liabilities
Total LiabilitiesCr
086457672
Current Assets
Current AssetsCr
070365414
Non Current Assets
Non Current AssetsCr
01692258
Total Assets
Total AssetsCr
086457672

Cash Flow

Consolidated
Standalone
Financial YearMar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-7-86-101
Investing Cash Flow
Investing Cash FlowCr
-31-125-5
Financing Cash Flow
Financing Cash FlowCr
3731514
Net Cash Flow
Net Cash FlowCr
-2103-92
Free Cash Flow
Free Cash FlowCr
-8-9133
CFO To PAT
CFO To PAT%
-400.0-7,140.6-326.5
CFO To EBITDA
CFO To EBITDA%
-395.3-2,579.5-235.0
Financial YearMar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-7-86-101
Investing Cash Flow
Investing Cash FlowCr
-31-125-5
Financing Cash Flow
Financing Cash FlowCr
3731514
Net Cash Flow
Net Cash FlowCr
-2103-92
Free Cash Flow
Free Cash FlowCr
-8-9133
CFO To PAT
CFO To PAT%
-400.0-7,140.6-326.5
CFO To EBITDA
CFO To EBITDA%
-395.3-2,579.5-235.0

Ratios

Consolidated
Standalone
Financial YearMar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
13,3425,7272,6212,448
Price To Earnings
Price To Earnings
2,402.53,903.08.289.8
Price To Sales
Price To Sales
8.0159.351.78.56.7
Price To Book
Price To Book
-5.441.616.90.75.0
EV To EBITDA
EV To EBITDA
130.01,777.51,663.361.952.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
100.020.616.5
OPM
OPM%
8.58.93.014.012.4
NPM
NPM%
-20.38.81.110.16.7
ROCE
ROCE%
5.02.70.711.411.4
ROE
ROE%
13.72.30.48.18.1
ROA
ROA%
-10.32.10.34.64.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
13,3425,7272,6212,448
Price To Earnings
Price To Earnings
2,402.53,903.08.289.8
Price To Sales
Price To Sales
8.0159.351.78.56.7
Price To Book
Price To Book
-5.441.616.90.75.0
EV To EBITDA
EV To EBITDA
130.01,777.51,663.361.952.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
100.020.616.5
OPM
OPM%
8.58.93.014.012.4
NPM
NPM%
-20.38.81.110.16.7
ROCE
ROCE%
5.02.70.711.411.4
ROE
ROE%
13.72.30.48.18.1
ROA
ROA%
-10.32.10.34.64.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Fischer Medical Ventures Ltd

  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/agn1j95tf4rzb0sx3l4lr6ez.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/zrj5to65fhgjetihbo5vdqt1.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/lih98dfcpyaidguzqkfrijbq.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/nlct6s25x18ucg6821y15ygk.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/5ef6cc6nky6cfexikqsfbtej.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/6wop8tyn8zq7l257kwr0b5gj.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/6w7dxb5l2b4r15u7ujtuwdu9.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/ww0r3cj2n76hac3ldov0x6p3.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/ke24ephvdw3m1fpt43x8ni3r.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/vs39tvf3aeu785k63gckdypl.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/e0bhjw54l11smg798qvy9a2i.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/5mada92vbwi6oac8obcw3kn3.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/e15z4k6fa428sjibrehddljh.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/8hpw0g6ihmcacoo4wx5a7jzr.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/p7ppx14vqhj4dv275swcev94.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/uav7cxwcds1apvalay3vzbzg.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/0f1oshsduyxvesh8cjlcsnu1.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/r6ky3zdzce42ih2bxcucyk4c.pdf

Concall Transcript Summaries — Fischer Medical Ventures Ltd

  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/BSE%3AFISCHER/transcript-notes/202509/agn1j95tf4rzb0sx3l4lr6ez.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies